Author:
Carpentier Jean-Pierre,Pouliquen Gilbert,Pétrognani Roland
Reference135 articles.
1. P55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 study group;Abraham;JAMA,1997
2. Efficacy and safety of monoclonal antibody to human necrosis factor-α in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial;Abraham;JAMA,1995
3. Antibiothérapie empirique en réanimation. In :;Albanèse,1996
4. Oxygen delivery and consumption in patients with hyperdynamic septic shock;Astiz;Crit Care Med,1987
5. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial;Astiz;Crit Care Med,1995